INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 424m ago
HOUSE PTR24m ago
SEC 13F24m ago
ROBINHOOD CHAIN24m ago
SEC FORM 4/Grant or awardVerified data

Koppikar Utpal reported INSM

Director · INSMED Inc · Common Stock

Side
A
Value
—
Shares
6,139
Price
—
Executed
Oct 19, 2026
Disclosed
Oct 20, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Oct 19 executedOct 20, 2026 disclosed

INSM · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
9/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Grant or award — administrative, little informational value

  • Relative size+1 / 25

No reported dollar value · new position

  • Filing timing0 / 15

    Disclosed 1 business day after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · INSM

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    9
    HP
    Hudson PaulDirector
    INSMINSMED Inc
    Grant or award
    		A—
    6,139 sh
    		Oct 19, 2026Oct 20, 2026
    traded Oct 19, 2026
    		+1dSEC FORM 4

    Evidence

    15
    FD
    Flammer Martina M.D.Chief Medical Officer
    INSMINSMED Inc
    Open-market sale · 10b5-1 plan
    		SELL$2.37M
    18.3K sh
    		Aug 6, 2026Aug 7, 2026
    traded Aug 6, 2026
    		+1dSEC FORM 4

    Evidence

    4
    FD
    Flammer Martina M.D.Chief Medical Officer
    INSMINSMED Inc
    Option exercise · 10b5-1 plan
    		M—
    18.3K sh
    		Aug 6, 2026Aug 7, 2026
    traded Aug 6, 2026
    		+1dSEC FORM 4

    Evidence

    6
    FD
    Flammer Martina M.D.Chief Medical Officer
    INSMINSMED Inc
    Option exercise · 10b5-1 plan
    		M$346K
    18.3K sh
    		Aug 6, 2026Aug 7, 2026
    traded Aug 6, 2026
    		+1dSEC FORM 4

    Evidence

    11
    FD
    Flammer Martina M.D.Chief Medical Officer
    INSMINSMED Inc
    Open-market sale · 10b5-1 plan
    		SELL$1.13M
    8,895 sh
    		Aug 6, 2026Aug 7, 2026
    traded Aug 6, 2026
    		+1dSEC FORM 4

    Evidence

    0
    FD
    Flammer Martina M.D.Chief Medical Officer
    INSMINSMED Inc
    Option exercise · 10b5-1 plan
    		M—
    8,895 sh
    		Aug 6, 2026Aug 7, 2026
    traded Aug 6, 2026
    		+1dSEC FORM 4

    Evidence

    0
    FD
    Flammer Martina M.D.Chief Medical Officer
    INSMINSMED Inc
    Option exercise · 10b5-1 plan
    		M$230K
    8,895 sh
    		Aug 6, 2026Aug 7, 2026
    traded Aug 6, 2026
    		+1dSEC FORM 4

    Evidence

    25
    Josh GottheimerDJoint
    INSMINSMED Inc
    Partial sale
    		SELL$1,001 – $15KJun 10, 2026Jul 7, 2026
    traded Jun 10, 2026
    		+27dHOUSE PTR

    Evidence

    9
    BS
    Butera SamueleSVP, GM, Global Respiratory
    INSMINSMED Inc
    Grant or award
    		A—
    12.6K sh
    		Jun 23, 2026Jun 24, 2026
    traded Jun 23, 2026
    		+1dSEC FORM 4

    Evidence

    6
    SA
    Smith Michael AlexanderChief Legal Officer
    INSMINSMED Inc
    Open-market sale · 10b5-1 plan
    		SELL$173K
    1,806 sh
    		Jun 22, 2026Jun 24, 2026
    traded Jun 22, 2026
    		+2dSEC FORM 4

    Evidence

    9
    BS
    Butera SamueleSVP, GM, Global Respiratory
    INSMINSMED Inc
    Grant or award
    		A—
    7,342 sh
    		Jun 23, 2026Jun 24, 2026
    traded Jun 23, 2026
    		+1dSEC FORM 4

    Evidence

    26
    SA
    Smith Michael AlexanderChief Legal Officer
    INSMINSMED Inc
    Open-market sale
    		SELL$221K
    2,159 sh
    		Jun 3, 2026Jun 5, 2026
    traded Jun 3, 2026
    		+2dSEC FORM 4

    Evidence

    24
    SA
    Smith Michael AlexanderChief Legal Officer
    INSMINSMED Inc
    Open-market sale
    		SELL$477K
    4,109 sh
    		May 13, 2026May 15, 2026
    traded May 13, 2026
    		+2dSEC FORM 4

    Evidence

    4
    SA
    Smith Michael AlexanderChief Legal Officer
    INSMINSMED Inc
    Option exercise · 10b5-1 plan
    		M—
    5,649 sh
    		Mar 30, 2026Mar 31, 2026
    traded Mar 30, 2026
    		+1dSEC FORM 4

    Evidence

    6
    SA
    Smith Michael AlexanderChief Legal Officer
    INSMINSMED Inc
    Option exercise · 10b5-1 plan
    		M$390K
    14.0K sh
    		Mar 30, 2026Mar 31, 2026
    traded Mar 30, 2026
    		+1dSEC FORM 4

    Evidence

    0
    SA
    Smith Michael AlexanderChief Legal Officer
    INSMINSMED Inc
    Option exercise · 10b5-1 plan
    		M$96K
    5,649 sh
    		Mar 30, 2026Mar 31, 2026
    traded Mar 30, 2026
    		+1dSEC FORM 4

    Evidence

    4
    SA
    Smith Michael AlexanderChief Legal Officer
    INSMINSMED Inc
    Option exercise · 10b5-1 plan
    		M—
    14.0K sh
    		Mar 30, 2026Mar 31, 2026
    traded Mar 30, 2026
    		+1dSEC FORM 4

    Evidence

    15
    SA
    Smith Michael AlexanderChief Legal Officer
    INSMINSMED Inc
    Open-market sale · 10b5-1 plan
    		SELL$2.96M
    19.6K sh
    		Mar 30, 2026Mar 31, 2026
    traded Mar 30, 2026
    		+1dSEC FORM 4

    Evidence

    6
    FD
    Flammer Martina M.D.Chief Medical Officer
    INSMINSMED Inc
    Open-market sale · 10b5-1 plan
    		SELL$132K
    869 sh
    		Feb 5, 2026Feb 6, 2026
    traded Feb 5, 2026
    		+1dSEC FORM 4

    Evidence

    22
    SA
    Smith Michael AlexanderChief Legal Officer
    INSMINSMED Inc
    Open-market sale
    		SELL$100K
    640 sh
    		Feb 3, 2026Feb 4, 2026
    traded Feb 3, 2026
    		+1dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001628280-26-066528
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Oct 19, 2026
    Published
    Oct 20, 2026
    Ingested by INSIDER
    Nov 5, 02:10 UTC
    Last re-read
    Nov 5, 02:10 UTC

    Extracted facts

    Filer
    Koppikar Utpal
    Role
    Director
    Transaction
    Grant or awardAs filed: “A”
    Asset
    INSMED Inc
    Ticker
    INSM
    Shares
    6,139
    Execution date (reported)
    Oct 19, 2026
    Owned after transaction
    6,139 shares
    Days from execution to publication
    1

    What this establishes

    Koppikar Utpal filed this Form 4 reporting a grant or award of INSM on Oct 19, 2026. It became public on Oct 20, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Director
    Koppikar Utpalcik:0001742696
    Issuer
    INSMED Inccik:0001104506

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.